SARS-COV-2 IMMUNOASSAY METHOD AND IMMUNOASSAY KIT, AND MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT THEREOF

The present invention provides a SARS-CoV-2 immunoassay method comprising a step for contacting a biological sample with a monoclonal antibody or an antibody fragment thereof, said monoclonal antibody binding to the nucleocapsid protein of SARS-CoV-2, wherein the monoclonal antibody or an antibody f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	OCHIAI Yasushi, HEWSON Christopher Kenta, HIROTA Jiro, YAJI Shohei, KOHNO Keigo, ASAI Tomohide, UNO Satoru
Format:	Patent
Sprache:	eng ; fre ; jpn
Schlagworte:	APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides a SARS-CoV-2 immunoassay method comprising a step for contacting a biological sample with a monoclonal antibody or an antibody fragment thereof, said monoclonal antibody binding to the nucleocapsid protein of SARS-CoV-2, wherein the monoclonal antibody or an antibody fragment thereof binds to SARS-CoV-2 having been treated with serine protease. La présente invention concerne un procédé de dosage immunologique du SARS-CoV-2 comprenant une étape de mise en contact d'un échantillon biologique avec un anticorps monoclonal ou un fragment d'anticorps associé, ledit anticorps monoclonal se liant à la protéine de nucléocapside du SARS-CoV-2, l'anticorps monoclonal ou un fragment d'anticorps associé se liant au SARS-CoV-2 ayant été traité avec de la sérine protéase. 本発明により、ＳＡＲＳ－ＣｏＶ－２の免疫測定方法であって、生体試料と、ＳＡＲＳ－ＣｏＶ－２のヌクレオカプシドタンパク質と結合するモノクローナル抗体又はその抗体断片とを接触させる工程を含み、前記モノクローナル抗体又はその抗体断片が、セリンプロテアーゼで処理したＳＡＲＳ－ＣｏＶ－２と結合する、免疫測定方法が提供される。